A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021

We have previously reported on the susceptibility and epidemiology of Clostridioides difficile isolates from six geographically dispersed medical centers in the United States. This current survey was conducted with isolates collected in 2020–2021 from six geographically dispersed medical centers in...

Descripción completa

Detalles Bibliográficos
Autores principales: Snydman, D. R., McDermott, L. A., Thorpe, C. M., Goldstein, E. J. C., Schuetz, A. N., Johnson, S., Gerding, D. N., Gluck, L., Bourdas, D., Carroll, K. C., Lancaster, C. K., Garey, K. W., Wang, Q., Walk, S. T., Duperchy, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583687/
https://www.ncbi.nlm.nih.gov/pubmed/37728368
http://dx.doi.org/10.1128/aac.00349-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583687/
https://www.ncbi.nlm.nih.gov/pubmed/37728368
http://dx.doi.org/10.1128/aac.00349-23

Ejemplares similares